Johns Hopkins Medicine

Glaucoma can cause vision loss that's currently irreversible. But now scientists have found that removing a membrane in the eye could help transplanted cells migrate into the optic nerve and repair the connections, potentially restoring lost vision.

A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to come” with larger a Phase 2 trial well underway.

When someone is recovering from surgery, they're typically encouraged to go for walks down the hospital hallways. Scientists have now found that by repurposing an existing device, it's possible to ascertain how much patients are heeding that advice.

Last week the FDA approved the experimental use of blood from recovered COVID-19 subjects as a treatment for newly infected patients. The therapy harks back to the 1890s, and it may be the stop-gap we need while other treatments are in development.

Statin drugs are commonly taken to help manage cholesterol levels. But now, researchers at Johns Hopkins Medicine have found that they may also kill some cancer cells by starving them of nutrients, and uncovered the mechanism for how that can happen.

Scientists at Johns Hopkins Kimmel Cancer Center are reporting an exciting advance in the field of immunotherapy, demonstrating that engineered bone marrow cells can slow the growth of prostate and pancreatic cancers in mice.

Sparking new dogs versus cats arguments, a study is suggesting exposure to a pet dog over a child’s first years can be linked to a lower risk of developing schizophrenia as an adult. The same correlation was not seen in children raised with cats.

In a first for the US, Johns Hopkins University is launching a research center dedicated to investigating psychedelic compounds.

A massive umbrella study, encompassing 277 clinical trials, into the effects of nutritional supplements and dietary interventions has concluded almost all vitamin and mineral supplements play no role in protecting from cardiovascular disease, or extending one’s lifespan.

A rigorous animal study has demonstrated how the misfolded proteins thought to cause Parkinson’s disease may originate in the gut, and travel up to the brain via the vagus nerve. This research builds on evidence pointing to a gut-brain connection in the disease and hints at new treatment pathways.

Research has revealed some cases of schizophrenia can be associated with abnormal protein buildup in the brain similar to that seen in neurodegenerative disorders like Alzheimer's. It's hoped the discovery will lead to better diagnostic strategies identifying specific types of schizophrenia.

A new study, led by researchers from the Johns Hopkins University School of Medicine, has described the discovery of a new kind of immune cell that is hypothesized to play a fundamental role in the development of type 1 diabetes.